MB

Mitesh Babubhai Patel

Active Director Director DIN 11076202
DIN 11076202 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mitesh Babubhai Patel

Data last updated:

Mitesh Babubhai Patel is a Director at Zeochem Anticorr Private Limited (since 2025).

DIN 11076202
Primary Designation Director
First Appointment 25 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeochem Anticorr Private Limited U20119GJ2025PTC162133
Director25 Apr 20252025Active

Board colleagues of Mitesh Babubhai Patel

Directorship timeline

Open interactive timeline →
Zeochem Anticorr Private Limited
Premium access

Shareholding and investment profile for Mitesh Babubhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mitesh Babubhai Patel

Mitesh Babubhai Patel currently holds 1 directorship: Zeochem Anticorr Private Limited (Director, since 25 Apr 2025).

Mitesh Babubhai Patel was first appointed on 25 Apr 2025 as Director at Zeochem Anticorr Private Limited.

The current boards of Mitesh Babubhai Patel's companies include Hareshkumar Kantilal Patel (Zeochem Anticorr Private Limited), Jigisha Patel (Zeochem Anticorr Private Limited), Jignaben Patel (Zeochem Anticorr Private Limited), Jignasha Hareshkumar Patel (Zeochem Anticorr Private Limited), Paresh Babubhai Patel (Zeochem Anticorr Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available